RSAD1

gene
On this page

Also known as FLJ11164HemW

Summary

RSAD1 (radical S-adenosyl methionine domain containing 1, HGNC:25634) is a protein-coding gene on chromosome 17q21.33, encoding Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Q9HA92). May be a heme chaperone, appears to bind heme. It is a selective cancer dependency (DepMap: 17.3% of cell lines).

Enables heme binding activity. Predicted to be involved in porphyrin-containing compound biosynthetic process. Located in mitochondrion.

Source: NCBI Gene 55316 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 83 total
  • Cancer dependency (DepMap): dependent in 17.3% of screened cell lines
  • MANE Select transcript: NM_018346

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25634
Approved symbolRSAD1
Nameradical S-adenosyl methionine domain containing 1
Location17q21.33
Locus typegene with protein product
StatusApproved
AliasesFLJ11164, HemW
Ensembl geneENSG00000136444
Ensembl biotypeprotein_coding
OMIM620590
Entrez55316

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 9 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay

ENST00000258955, ENST00000443328, ENST00000504284, ENST00000506211, ENST00000509398, ENST00000510554, ENST00000513650, ENST00000515221, ENST00000859048, ENST00000859049, ENST00000859050, ENST00000859051, ENST00000859052, ENST00000926999, ENST00000943159

RefSeq mRNA: 1 — MANE Select: NM_018346 NM_018346

CCDS: CCDS11569

Canonical transcript exons

ENST00000258955 — 9 exons

ExonStartEnd
ENSE000007370525047988050480084
ENSE000010184655048474450485974
ENSE000034794505048209150482456
ENSE000035109245048334050483487
ENSE000035207205048444250484545
ENSE000035294055048264350482706
ENSE000035579935047962950479762
ENSE000035708935047886050479019
ENSE000036592435048370650483760

Expression profiles

Bgee: expression breadth ubiquitous, 280 present calls, max score 97.33.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.0605 / max 135.4164, expressed in 1789 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
16166711.02361767
1616663.68611568
1616651.3508870

Top tissues by expression

291 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right hemisphere of cerebellumUBERON:001489097.33gold quality
cerebellar hemisphereUBERON:000224597.23gold quality
cerebellar cortexUBERON:000212997.11gold quality
body of pancreasUBERON:000115096.15gold quality
metanephros cortexUBERON:001053395.94gold quality
cerebellumUBERON:000203795.91gold quality
endocervixUBERON:000045895.72gold quality
apex of heartUBERON:000209895.50gold quality
right adrenal glandUBERON:000123394.89gold quality
gastrocnemiusUBERON:000138894.86gold quality
left adrenal glandUBERON:000123494.77gold quality
right adrenal gland cortexUBERON:003582794.77gold quality
right lobe of thyroid glandUBERON:000111994.71gold quality
left adrenal gland cortexUBERON:003582594.70gold quality
body of stomachUBERON:000116194.41gold quality
right ovaryUBERON:000211894.37gold quality
muscle of legUBERON:000138394.36gold quality
left lobe of thyroid glandUBERON:000112094.35gold quality
adrenal cortexUBERON:000123594.33gold quality
left ovaryUBERON:000211994.13gold quality
right frontal lobeUBERON:000281094.01gold quality
body of uterusUBERON:000985393.96gold quality
thyroid glandUBERON:000204693.62gold quality
right lobe of liverUBERON:000111493.56gold quality
ectocervixUBERON:001224993.55gold quality
adrenal glandUBERON:000236993.50gold quality
heart left ventricleUBERON:000208493.27gold quality
nucleus accumbensUBERON:000188293.26gold quality
putamenUBERON:000187493.18gold quality
right uterine tubeUBERON:000130292.94gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

46 targeting RSAD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6748-5P100.0065.811057
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-4283100.0066.422097
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-368699.9070.532432
HSA-MIR-808099.8267.521342
HSA-MIR-548AG99.7769.251492
HSA-MIR-197699.7465.481127
HSA-MIR-120099.7170.421838
HSA-MIR-548AI99.6969.241494
HSA-MIR-548BA99.6969.141514
HSA-MIR-570-5P99.6969.241494
HSA-MIR-671-5P99.5267.111277
HSA-MIR-608199.4866.071446
HSA-MIR-4728-3P99.4768.94981
HSA-MIR-766-3P99.4765.241811
HSA-MIR-519D-5P99.4169.302057
HSA-MIR-6853-3P99.3670.791558
HSA-MIR-6507-3P99.3567.321059
HSA-MIR-569399.2466.671106
HSA-MIR-3619-5P99.0068.872308
HSA-MIR-445198.8268.171455
HSA-MIR-6794-3P98.7666.99894
HSA-MIR-214-3P98.7168.122128
HSA-MIR-76198.7168.072051
HSA-MIR-797798.6566.182590
HSA-MIR-3145-5P98.5767.83900
HSA-MIR-6824-3P98.4467.621154

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 17.3% of screened cell lines.

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriorsad1ENSDARG00000077698
mus_musculusRsad1ENSMUSG00000039096
rattus_norvegicusRsad1ENSRNOG00000065974

Protein

Protein identifiers

Radical S-adenosyl methionine domain-containing protein 1, mitochondrialQ9HA92 (reviewed: Q9HA92)

Alternative names: Putative heme chaperone

All UniProt accessions (4): Q9HA92, H0Y934, H0Y9X4, K7EKD3

UniProt curated annotations — full annotation on UniProt →

Function. May be a heme chaperone, appears to bind heme. Homologous bacterial proteins do not have oxygen-independent coproporphyrinogen-III oxidase activity. Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine.

Subcellular location. Mitochondrion.

Miscellaneous. Might carry two S-adenosyl-L-methionine binding sites with only one binding to the iron-sulfur cluster.

Similarity. Belongs to the anaerobic coproporphyrinogen-III oxidase family. HemW subfamily.

Isoforms (2)

UniProt IDNamesCanonical?
Q9HA92-11yes
Q9HA92-22

RefSeq proteins (1): NP_060816* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004559HemW-likeFamily
IPR006638Elp3/MiaA/NifB-like_rSAMDomain
IPR007197rSAMDomain
IPR010723HemN_CDomain
IPR013785Aldolase_TIMHomologous_superfamily
IPR034505Coproporphyrinogen-III_oxidaseFamily
IPR058240rSAM_sfHomologous_superfamily

Pfam: PF04055, PF06969

UniProt features (22 total): binding site 10, splice variant 3, sequence variant 3, sequence conflict 3, transit peptide 1, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9HA92-F191.000.85

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (10): 158; 170; 195; 43; 49; 53; 56; 98; 99–100; 131

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (1): porphyrin-containing compound biosynthetic process (GO:0006779)

GO Molecular Function (6): coproporphyrinogen oxidase activity (GO:0004109), heme binding (GO:0020037), metal ion binding (GO:0046872), 4 iron, 4 sulfur cluster binding (GO:0051539), catalytic activity (GO:0003824), iron-sulfur cluster binding (GO:0051536)

GO Cellular Component (2): cytoplasm (GO:0005737), mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
porphyrin-containing compound metabolic process1
tetrapyrrole biosynthetic process1
oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor1
tetrapyrrole binding1
cation binding1
iron-sulfur cluster binding1
molecular_function1
metal cluster binding1
intracellular anatomical structure1
cellular anatomical structure1
cytoplasm1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

3019 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RSAD1TYW1Q9NV66505
RSAD1MOCS1Q9NZB8490
RSAD1PIGZQ86VD9477
RSAD1CDK5RAP1Q96SZ6475
RSAD1DPM3Q9P2X0474
RSAD1DPM2O94777462
RSAD1ELP3Q9H9T3450
RSAD1TMEM161AQ9NX61449
RSAD1DPM1O60762448
RSAD1RSAD2Q8WXG1444
RSAD1METTL25BQ96FB5444
RSAD1CZIBQ9NWV4435
RSAD1GARRE1O15063433
RSAD1BOLA1Q9Y3E2422
RSAD1OR5H14A6NHG9418
RSAD1THNSL1Q8IYQ7418

IntAct

63 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
NDUFS6NDUFS8psi-mi:“MI:0914”(association)0.640
BPNT1GTPBP10psi-mi:“MI:0914”(association)0.530
KLHDC2PFDN1psi-mi:“MI:0914”(association)0.530
PNLIPLAMC1psi-mi:“MI:0914”(association)0.530
WDR53BLVRApsi-mi:“MI:0914”(association)0.530
ARHGEF26CPS1psi-mi:“MI:0914”(association)0.530
WDR53NACADpsi-mi:“MI:0914”(association)0.350
TRMT1HDAC3psi-mi:“MI:0914”(association)0.350
LIG3NDUFS6psi-mi:“MI:0914”(association)0.350
SDHBCLPXpsi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
MGARPBTAF1psi-mi:“MI:0914”(association)0.350
ZNF460ZNF320psi-mi:“MI:0914”(association)0.350
UQCRFS1VWA8psi-mi:“MI:0914”(association)0.350
FBLN2ZNF316psi-mi:“MI:0914”(association)0.350
PTH2RMETTL15psi-mi:“MI:0914”(association)0.350
RTCANDUFA4psi-mi:“MI:0914”(association)0.350
TRAV20MAP2K7psi-mi:“MI:0914”(association)0.350
TRMUIFT56psi-mi:“MI:0914”(association)0.350
TRIM43VWA8psi-mi:“MI:0914”(association)0.350
QRSL1VWA8psi-mi:“MI:0914”(association)0.350
SHC2VWA8psi-mi:“MI:0914”(association)0.350
YARS2VWA8psi-mi:“MI:0914”(association)0.350
MRPS24VWA8psi-mi:“MI:0914”(association)0.350
AMACRVWA8psi-mi:“MI:0914”(association)0.350
ACSM5VWA8psi-mi:“MI:0914”(association)0.350
AK4VWA8psi-mi:“MI:0914”(association)0.350

BioGRID (59): RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS), RSAD1 (Affinity Capture-MS)

ESM2 similar proteins: A4FV98, A5D7B1, A5PK51, A6QLN9, A8MUP2, D3ZVU9, O15527, O35595, O75078, O95848, P57775, Q05B60, Q06643, Q14728, Q14CX5, Q1LZB9, Q27HK4, Q2T9T5, Q2TBS1, Q3UGX3, Q4R3I0, Q4V892, Q58CT4, Q5E9H2, Q5RCI5, Q5SUV1, Q5TM22, Q642A6, Q6IA17, Q6PCB0, Q6XQN6, Q862Z7, Q8N8L6, Q8R2R5, Q8R2Z5, Q8R366, Q8WUG5, Q95JH0, Q95JH2, Q969P0

Diamond homologs: A4IGH2, A5D7B1, P43899, P52062, P54304, P73245, P95506, P9WP72, P9WP73, Q54VE8, Q5SUV1, Q8K928, Q9HA92, O34162, P57615, P77915, O67886, P0A1E1, P0A1E2, P32131, P74132, Q89A47, Q9CGF7, Q51676, O31381, P33770, P55477, P95651, Q796V8, O25376, O31067, O59545, P51008, Q9ZLH0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

83 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance77
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1656 predictions. Top by Δscore:

VariantEffectΔscore
17:50479020:G:GGdonor_gain1.0000
17:50479627:A:AGacceptor_gain1.0000
17:50479627:AGT:Aacceptor_gain1.0000
17:50479628:G:GGacceptor_gain1.0000
17:50479628:GT:Gacceptor_gain1.0000
17:50479628:GTG:Gacceptor_gain1.0000
17:50479759:AACGG:Adonor_loss1.0000
17:50479761:CGG:Cdonor_loss1.0000
17:50479762:GGT:Gdonor_loss1.0000
17:50479763:G:Tdonor_loss1.0000
17:50479989:G:GTdonor_gain1.0000
17:50482089:A:AGacceptor_gain1.0000
17:50482090:G:GGacceptor_gain1.0000
17:50482452:GGAAT:Gdonor_gain1.0000
17:50482453:GAAT:Gdonor_gain1.0000
17:50482453:GAATG:Gdonor_gain1.0000
17:50482454:A:Tdonor_gain1.0000
17:50482457:G:GGdonor_gain1.0000
17:50482457:GTAA:Gdonor_loss1.0000
17:50482458:T:Gdonor_loss1.0000
17:50483485:GCT:Gdonor_gain1.0000
17:50478967:G:GTdonor_gain0.9900
17:50479015:TACAC:Tdonor_gain0.9900
17:50479018:AC:Adonor_gain0.9900
17:50479018:ACGT:Adonor_loss0.9900
17:50479020:G:GCdonor_loss0.9900
17:50479021:TGA:Tdonor_loss0.9900
17:50479022:GAGTA:Gdonor_loss0.9900
17:50479023:AGT:Adonor_loss0.9900
17:50479620:T:Aacceptor_gain0.9900

AlphaMissense

2800 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:50479665:T:CF58L0.996
17:50479667:C:AF58L0.996
17:50479667:C:GF58L0.996
17:50480065:G:TR152M0.994
17:50482701:G:AG300E0.994
17:50479893:T:CF95L0.993
17:50479895:C:AF95L0.993
17:50479895:C:GF95L0.993
17:50479914:A:CS102R0.993
17:50479916:T:AS102R0.993
17:50479916:T:GS102R0.993
17:50483422:G:CW329C0.992
17:50483422:G:TW329C0.992
17:50479660:G:AC56Y0.991
17:50479629:T:AW46R0.990
17:50479629:T:CW46R0.990
17:50479017:C:GH45D0.989
17:50480003:G:CE131D0.989
17:50480003:G:TE131D0.989
17:50482445:T:CF277L0.989
17:50482447:T:AF277L0.989
17:50482447:T:GF277L0.989
17:50483420:T:AW329R0.989
17:50483420:T:CW329R0.989
17:50482444:C:AN276K0.988
17:50482444:C:GN276K0.988
17:50482652:A:CS284R0.988
17:50482654:T:AS284R0.988
17:50482654:T:GS284R0.988
17:50479639:G:AC49Y0.987

dbSNP variants (sampled 300 via entrez): RS1000136382 (17:50479538 AGGGGTG>A,AGGGGTGGGGGTG), RS1000176049 (17:50481556 T>C), RS1000580099 (17:50479839 A>C), RS1000696835 (17:50481310 C>G,T), RS1001075304 (17:50485672 C>G,T), RS1001320411 (17:50484205 G>T), RS1001556946 (17:50480546 G>A), RS1001598676 (17:50479265 T>C), RS1001777657 (17:50480847 C>T), RS1001964726 (17:50485133 C>A,T), RS1002324793 (17:50477757 G>T), RS1003063199 (17:50478105 C>A,T), RS1003792216 (17:50478333 G>A), RS1004390154 (17:50479819 G>A,C,T), RS1004712025 (17:50484742 A>G)

Disease associations

OMIM: gene MIM:620590 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Acetaminophendecreases expression, increases expression2
Cisplatinaffects cotreatment, increases expression, decreases expression2
Valproic Acidincreases expression, affects expression2
pirinixic acidaffects binding, increases activity, increases expression1
trichostatin Aincreases expression1
methylparabenincreases expression1
sodium arsenitedecreases expression1
cobaltous chloridedecreases expression1
perfluorooctane sulfonic acidincreases expression1
abrinedecreases expression1
jinfukangaffects cotreatment, increases expression1
Benzo(a)pyreneaffects methylation1
Doxorubicinincreases expression1
Methotrexateincreases expression1
Methyl Methanesulfonatedecreases expression1
Quercetindecreases expression1
Rotenoneincreases expression1
Seleniumincreases expression1
Silicon Dioxideincreases expression1
Smokedecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Vitamin Eincreases expression1
Cyclosporineincreases expression1
Antirheumatic Agentsincreases expression1
Cadmium Chloridedecreases expression1
Copper Sulfatedecreases expression1
Acrylamidedecreases expression1
Vitamin K 3affects expression1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_TJ80HAP1 RSAD1 (-) 1Cancer cell lineMale
CVCL_XS32HAP1 RSAD1 (-) 2Cancer cell lineMale
CVCL_XS33HAP1 RSAD1 (-) 3Cancer cell lineMale
CVCL_XS34HAP1 RSAD1 (-) 4Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.